Persistence of immunophenotypically aberrant CD34+ myeloid progenitors is frequent in bone marrow of patients with myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms treated with hypomethylating agents
暂无分享,去创建一个
G. Garcia-Manero | M. Routbort | E. Jabbour | L. Medeiros | J. Jorgensen | Sa A. Wang | Lan-shan Huang | Maitrayee Goswami